Archive for the ‘Cell Therapy’ Category

One Gold
Get the best offer here redirect.viglink.com?key=f341fd9454fc162be8b38d504acbd4e1 out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fdp%2FB0079QLQ0G Product Description One Gold Experience the Anti-Aging Power of the New Generation 24K Nano Gold Stem Cell Therapy Mask. This excellent product by BeautyMedica Lab offers an innovative Transdermal Delivery System with a unique blend of transforming growth factors (TGF), amino acids, antioxidants and peptides.Sheet form of the mask makes it extremely easy to apply to the face and allowing the ingredients to be absorbed into the skin slowly melting under body temperature. The Mask was formulated to Re-activate stem cells and stimulate new skin development. Increase collagen production and elastin synthesis. Minimize appearance of fine lines and wrinkles. Enhance moisture with Y-PGA and refine skin structure. Whiten the skin and reduce melanin. Restore youthful healthy looking skin and creates radiant skin appearance.For more info, please visit 24K Gold Mask presentation video by Beauty Medical Laboratorys - http://www.youtube.comFrom:Pricilla DuongViews:1 0ratingsTime:00:58More inScience Technology

The rest is here:
One Gold - Video

Biologic Cell
Get the best offer here redirect.viglink.com?key=f341fd9454fc162be8b38d504acbd4e1 out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fdp%2FB0083UMZOI Product Description Biologic Cell Re-Activate your stem cells to make wrinkles disappear! Set of 4 - 1 oz. jars.Stem Cell Therapy is the newest bio-active topical cream that actually stimulates your own skin stem cells to grow smooth, supple, firm new skin.Three powerful ingredients, Phyko-AI-PF (increases skin production by 57%), Mitostime (re-activates stem cells), and Seractin (a youth compound targeted at decreasing your deepest wrinkles) all work together to help you turn back the clock.Results start to appear within 2 weeks of regular use.From:Lilliam FogleViews:0 0ratingsTime:00:58More inNews Politics

Continued here:
Biologic Cell - Video

Stem Cell Therapy For Parkinsons Disease | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy for Parkinson #39;s Disease is still under research and study. However, there are impressive results by patients using oral placenta as stem cell therapy for their Parkinson #39;s disease. An 81 years old Asian with Stage 2 Parkinson #39;s disease observed cessation of tremor after only 4 weeks of oral placenta stem cell therapy. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:194 8ratingsTime:11:49More inScience Technology

Read the original:
Stem Cell Therapy For Parkinsons Disease | Stem Cell Malaysia - Video

New technique to deliver stem cell therapy may help damaged eyes regain their sight
Engineers at the University of Sheffield have developed a new technique for delivering stem cell therapy to the eye which they hope will help the natural repair of eyes damaged by accident or disease.From:ResearchatSheffieldViews:0 0ratingsTime:01:31More inScience Technology

Continued here:
New technique to deliver stem cell therapy may help damaged eyes regain their sight - Video

MANILA, Philippines - A ranking official of the Catholic Bishops Conference of the Philippines (CBCP) considers immoral the embryonic stem cell therapy reportedly being used by politicians and actors for aesthetic purposes.

In an interview with Radio Veritas, CBCP-Episcopal Commission on Bioethics Chairman and Malolos Bishop Jose Oliveros said this medical procedure is against the belief of the Church. He said they are still assessing if the same could be said for stem cells from animals.

Pero yung sinasabi nila na pampabata sa mga politician at celebrities na sumailalim sa stem cell therapy ay immoral. Puwede namang ma-improve ang mukha ng isang tao, but it should be moral. Kapag gumamit ka ng immoral ay mali na yun, he said.

Embryo is still a maturing fetus.

He said the CBCP will come out with a pastoral statement regarding the matter once they are able to clarify certain matters with the Department of Health (DOH).

The DOH earlier warned people from using stem cells from aborted babies and human embryos.

The Philippine government will not allow the use of aborted fetuses or human embryosThere is a need to ensure that the biological raw materials are documented and validated and follow infection-free procedures, the DOH earlier said.

There is also a need to know if the materials to be injected came from animal or human tissues, it added.

More:
Stem cell therapy is immoral - bishop

SAN DIEGO, CA--(Marketwire - Nov 19, 2012) - Bio-Matrix Scientific Group, Inc. ( OTCQB : BMSN ) announced today that its wholly owned subsidiary, Regen BioPharma, Inc., has contracted Cascade Life Sciences, Inc. to research the safety and efficacy of Regen's HemaXellerate product usingmice models for testing.Cascade Life Sciences is a privately-owned San Diego-based company with a platform of stem cell related technologies that are being advanced to serve the research community and the commercial development of stem cell-based therapeutics. Sophia Khaldoyanidi, M.D., Ph.D. is the principal investigator of the study.

The results of Regen's study will provide the safety profile data required for filing of anInvestigational New Drug (IND) application for the product with the US Food and Drug Administration .Regen intends to file an IND Application in the fourth quarter of 2012 and conduct Phase I/II clinical trials during 2013 and 2014.

HemaXellerate offers the possibility of delivering a population of endothelial cells to restore blood production in patients with hematological conditions."Unlike current approaches of administering pharmaceuticals," said J. Christopher Mizer, President of Regen BioPharma, "our strategy is to heal the bone marrow by administering cells that provide the optimum mix of growth factors to stimulate the bone marrow into producing blood cells naturally."

Regen has submitted two provisional patent applications covering the use of different sources of endothelial cells to heal damaged bone marrow. These applications cover: (1) placental cells (61/648898 - Acceleration 0f Hematopoietic Reconstitution by Placental Endothelial and Endothelial Progenitor Cells); and (2) fat cells (61/670791 - Treatment of Hematopoietic Disorders).

About Bio-Matrix Scientific Group Inc. and Regen BioPharma, Inc.:

Bio-Matrix Scientific Group, Inc. ( OTCQB : BMSN ) is a biotechnology company developing regenerative medicine therapies. The Company is focused on human therapies that address unmet medical needs. Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to cardiovascular, hematology, oncology and other indications.

Regen BioPharma, Inc., a subsidiary of Bio-Matrix Scientific Group, Inc. ( OTCQB : BMSN ), is a biotechnology company focused on identifying undervalued regenerative medicine patents in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. To follow our development, visit us at http://www.regenbiopharma.com.

Disclaimer

This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks

Read this article:
Bio-Matrix' Regen BioPharma Initiates Pre-Clinical Study in Support of HemaXellerate(TM) Cell Therapy

cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy
http://www.cordbloodrecommendation.com These diseases include blood related, genetic and neurotic disorders. ""Banking the umbilical cord blood when your baby is born is a relatively new idea, the first operation using it to help cure a child with Leukemia was only done a little over 10 years ago. After processing of cells, comes the next procedure of cord blood preservation. There is also another option given by non-profit cord blood banks, of free programs through which one can store umbilical cord blood stem cell samples. A man can change his god-gifted features wishfully with the help of science. Given the progress that stem cell research and regenerative medicine have attained at present, and the promise that they show for the future, stem cell transplants may one day provide a cure for type 1 diabetes, heart disease, and brain injury, among other potentially life threatening and debilitating illnesses and conditions with inadequate treatment options today. With people not fully understanding how important stem cells could be for us, everybody agrees that more research need to be done in order to help understand all that. If there is any complication during delivery, the entire idea is abandoned. It is always wise to preserve this waste blood of the baby which is otherwise thrown away. You are injecting the patient with those same cells that created him!This can be done with the bone marrow transplants tooYes, stem cells are found in bone marrows too. It is a simple and ...From:luisantafeViews:0 0ratingsTime:01:31More inScience Technology

Read the original:
cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy - Video

NeoStem, Inc. (NYSE:NBS ("NeoStem" or the "Company"), an emerging leader in the fast growing cell therapy industry, today announced that it has been awarded a two year grant totaling $1,221,854 for "Repair of Bone Defects with Human Autologous Pluripotent Very Small Embryonic-Like Stem Cells (VSEL)", grant number 2R44DE022493-02A1, from the National Institute of Dental and Craniofacial Research (NIDCR), a division of the National Institutes of Health (NIH). This peer reviewed grant is to support a Phase 2 investigation and first approved NIH clinical study of VSELsTM in humans. The study will be headed by Denis O. Rodgerson, Ph.D., Director of Grants and Academic Liaison for NeoStem, in collaboration with co-investigators Drs. Russell Taichman and Laurie McCauley of the University of Michigan. Enrollment for this study is expected to begin in 2013.

This award will fund the evaluation of VSELTM stem cells as a potential treatment for periodontitis. The product candidate, an autologous therapy derived from a patient's own stem cells, is to be developed for use in the regeneration of bone tissue damaged by this disease. The award includes $706,682 for the first year and $515,172 for the second year of the project, and will cover the cost of the Investigational New Drug (IND) submission to the FDA for the product candidate.

Dr. Denis O. Rodgerson, Director of Grants and Academic Liaison for NeoStem, said, "We are pleased and honored that NIH has agreed to support further studies on bone regeneration by using VSELTM stem cells. This is an extension of our successful NIH funded collaboration with Dr. Taichman showing the production of human bone from human VSELsTM in a mouse model."

Periodontal disease is prevalent in the U.S. and affects up to 90% of the world population. The most severe cases of periodontal disease affect between 5% and 15% of the U.S. population, or between 15 and 47 million Americans. The incidence of periodontal disease is estimated to be between 1 and 3 million Americans annually, and growing at a 7% rate each year. Studies have shown that periodontal inflammation could have a role in the initiation or progression of coronary heart disease and stroke. Market research experts have estimated that severe periodontal disease represents a market between $1.25 and $1.5 billion annually.

Dr. Russell Taichman, Major Ash Collegiate Professor and Co-Director of the Scholars Program in Dental Leadership, Department of Periodontics & Oral Medicine, University of Michigan stated, "I am thrilled for the possibilities that this award opens. The chance to continue to partner with NeoStem to further develop regenerative therapies is significant. The validation that this award brings and the opportunity to establish a proof of concept, which may impact human health, is truly rewarding." Dr. Laurie McCauley, The William K. and Mary Anne Najjar Professor, Division of Periodontics Department of Periodontics and Oral Medicine, University of Michigan added, "This novel cell based therapeutic approach looks to validate scientifically sound pre-clinical studies and provide a vital translation to improved human patient care."

NeoStem has a worldwide exclusive license to VSEL technology which uses very small embryonic-like stem cells, a heterogeneous population of stem cells found in adult bone marrow that have properties similar to those of embryonic stem cells. NeoStem has shown that very small embryonic-like stem cells can be mobilized into the peripheral blood, enabling a minimally invasive means for collecting what it believes to be an important population of stem cells that may have the potential to achieve the positive benefits associated with embryonic stem cells without the ethical or moral dilemmas or the potential negative biological effects associated with embryonic stem cells.

Dr. Robin L. Smith, Chairman and CEO of NeoStem, added, "We are very excited about this important step of funding for what will be the first human clinical study for our VSELTM technology. Not only will this study expand our knowledge of how autologous cell therapy can treat periodontitis and other bone defects, but it represents a milestone for NeoStem as we move our development of VSELTM technology beyond animal models and into the clinic, paving the way for other potential VSELTM trials."

About NeoStem, Inc.

NeoStem, Inc. continues to develop and build on its core capabilities in cell therapy, capitalizing on the paradigm shift that we see occurring in medicine. In particular, we anticipate that cell therapy will have a significant role in the fight against chronic disease and in lessening the economic burden that these diseases pose to modern society. We are emerging as a technology and market leading company in this fast developing cell therapy market. Our multi-faceted business strategy combines a state-of-the-art contract development and manufacturing subsidiary, Progenitor Cell Therapy, LLC ("PCT"), with a medically important cell therapy product development program, enabling near and long-term revenue growth opportunities. We believe this expertise and existing research capabilities and collaborations will enable us to achieve our mission of becoming a premier cell therapy company.

Our contract development and manufacturing service business supports the development of proprietary cell therapy products. NeoStem's most clinically advanced therapeutic, AMR-001, is being developed at Amorcyte, LLC ("Amorcyte"), which we acquired in October 2011. Amorcyte is developing a cell therapy for the treatment of cardiovascular disease and is enrolling patients in a Phase 2 trial to investigate AMR-001's efficacy in preserving heart function after a heart attack. Athelos Corporation ("Athelos"), which is approximately 80%-owned by our subsidiary, PCT, is collaborating with Becton-Dickinson in the early clinical exploration of a T-cell therapy for autoimmune conditions. In addition, pre-clinical assets include our VSELTM Technology platform as well as our mesenchymal stem cell product candidate for regenerative medicine. Our service business and pipeline of proprietary cell therapy products work in concert, giving us a competitive advantage that we believe is unique to the biotechnology and pharmaceutical industries. Supported by an experienced scientific and business management team and a substantial intellectual property estate, we believe we are well positioned to succeed.

Read this article:
NeoStem Receives Notification Of $1.2 million NIH Grant Award For First Clinical Study Of VSELTM Technology In Humans

Mrs. Linda Flournoy
describes ger experience with Stem Cell Therapy PRPFrom:FLRegenerativeMedViews:14 0ratingsTime:02:27More inEducation

Continue reading here:
Mrs. Linda Flournoy - Video

Video 7 - November 14, 2012 - Adult Stem Cells Progress.wmv
Breif interview of my progress with Multiple Sclerosis with Adult Stem Cell therapy after my experience with Tysabri, Gilenya and Ampira failed.From:MSajourneyfromwithinViews:1 0ratingsTime:04:21More inEducation

Excerpt from:
Video 7 - November 14, 2012 - Adult Stem Cells Progress.wmv - Video

What Are Stem Cells and Stem Cell Therapy Stemenhance
From:Jennifer MarksViews:0 0ratingsTime:06:37More inEducation

More:
What Are Stem Cells and Stem Cell Therapy Stemenhance - Video

Hair Loss PRP-Stem Cell Therapy-2 month comparison- Large.m4v
http://www.newininstitute.com.au PRP Therapy was chosen instead of a Hair Transplant to treat an area of hair loss in a female. 2 month comparison Before and After photos show a highly successful outcome. Note that continued hair growth will occur over the coming months. Another procedure will need to be performed at around the peak period: 12-18 months when growth begins to slow. Newin Institute has uniquely developed processes and protocols for PRP and Adipose Stem Cell Therapy.From:Rhett BosnichViews:0 0ratingsTime:00:55More inScience Technology

Read the original here:
Hair Loss PRP-Stem Cell Therapy-2 month comparison- Large.m4v - Video

For Dr. Robert Janson-Mller, the science of fresh cell therapy is in his blood.

His grandfather, Dr. Philipp Janson was one of the few doctors who introduced the treatment in Germany. His father, Dr. Wolfgang Janson-Mller continued the work that was eventually passed on to him.

He was exposed to the revolutionary world of fresh cell therapy early on in life. The treatment uses live young cells from a donor animal like sheep to help regenerate damaged cells in the body. Dr. Mller practically grew up in his grandfather and father's clinic where he met the former's patients, some of whom still go to him for their regular treatments.

''A child always wants to grow up like his father and do the same thing. My father left it open for me. He told me I could do whatever I want, the same thing I am doing now for my daughter. I'm also head of a clinic in Munich. This is what I do besides cell treatment. We have a family practice. That is my main job,'' shares the 46-year-old German doctor who recently visited the Philippines to acquaint Filipinos with the science of fresh cell therapy.

Dr. Mller, who owns a fresh cell therapy laboratory and works as head doctor of Med Activ clinic in Munich, says that despite the growing market for it in America and Asia, there are only five doctors in Germany practicing the science. The treatment is known to deter degenerative diseases such as arthrosis, rheumatism and neurological disorders such as multiple sclerosis. But it is most popular as an anti-aging treatment. Recently, it has also been used to treat children with autism and Down syndrome.

Yet, Dr. Mller points out that fresh cell therapy is not a miracle cure for aging or these diseases. Some bodies accept the treatment while some don't. And, it doesn't treat every disease known to mankind.

Nevertheless, patients from all over the world still flock to his private clinic at the Prinzregent Hotel in Edenkoben, Germany to avail themselves of the treatment, which does not come cheap. One session would cost about $12,000 or R624,000.

''I don't treat patients with cancer, tuberculosis, AIDS, or those who are pregnant. We don't treat patients with acute inflammations like appendicitis. Aside from that, I need to see if it makes sense. If I don't see a possibility, I say no,'' he explains.

In this 60 Minutes interview, Dr. Mller shares how fresh cell therapy really works and how it can take more than just one, two, 20, 60 or even 100 treatments to get it right. Some may start as young as eight months old or continue the treatment at 99 years old. This just proves that a patient is never too young nor too old for this revolutionary treatment. (Angelo G. Garcia)

STUDENTS AND CAMPUSES BULLETIN (SCB): A lot of people are confused about the difference between stem cell and fresh cell therapy.

Link:
The cell therapist

David Kekich - Stem Cell Therapy Breakthrough
Centagen is developing technology to help millions of people who suffer from chronic pain, disease and injury with an advanced form of adult stem cell therapy. For more information go to http://www.indiegogo.comFrom:CentagenViews:325 118ratingsTime:02:35More inScience Technology

See the original post here:
David Kekich - Stem Cell Therapy Breakthrough - Video

Stem Cell Therapy | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy is a form of cell therapy that makes use of stem cells harvested from placenta for disease treatment. Stem cell therapy is also used for beauty, anti-aging and health rejuvenation purposes. The efficacy of stem cell therapy has been in practice for decades. Many rich and wealthy individuals and celebrities pay hefty price for stem cell therapy just to maintain youthfulness and vitality. For many severely ill-stricken people who have exhausted all means of conventional therapy look toward stem cell therapy for saving their condition and life. stemcellmalaysia.comFrom:stemcells2012Views:224 2ratingsTime:07:23More inHowto Style

Follow this link:
Stem Cell Therapy | Stem Cell Malaysia - Video

umbilical cord blood | Cord Blood - Life Saving Out of the Womb
http://www.cordbloodrecommendation.com The collected blood should be processed by specialists in the laboratory within 48 hours and stored properly. Stems cells are very important. Again, these are not hard and fast numbers but just estimates. This procedure also supplies a rapid chromosome analysis within high levels of accuracy. As we all know that it is rich in Hematopoietic stem cells. Extracting bone marrow is a very painful and difficult procedure, and if you have your own blood, then you do not need to make your family members go through the bone marrow transplant procedure. If your child is able to pass the pre-screening process, the program has been highly regarded and is an excellent, free alternative to private registry. Preserved stem cells are used when the body is in a weakened state from disease or treatments such as chemotherapy. Cord blood stem cell therapy has regenerative characteristics. This kind of disease typically attacks the neurons of the central nervous system in the brain. If they decide to donate to a public facility, there are no storage fees however because of privacy concerns all identification features are removed from that particular storage lot within a few years. How many years can a baby #39;s cord blood be saved?Cord blood banking is a relatively new concept. If they are able to grow sufficiently, the new cell will make new blood cells. If you have stem cells of your child, then you will not even need to find bone marrow donors in case your child isFrom:Implantes DentalesViews:0 0ratingsTime:01:18More inScience Technology

View original post here:
umbilical cord blood | Cord Blood - Life Saving Out of the Womb - Video

cord blood bank | Cheapest Cord Blood Banking
http://www.cordbloodrecommendation.com Cord blood will be the right answer for some diseases. One case is that of Stephen Sprague who was diagnosed with Chronic Myelogenous Leukemia (CML) in 1995. Once you catalog with a cord blood cache, they forward you a kit, containing all the crucial gear for collecting cord blood, along with instructions for the presence doctor, imparter or attention employees. As a parent, we have a choice. It will be easier to take advantage of these new possibilities if you have your own cord blood available for use. She sought umbilical cord blood stem cell therapy from the private Preventative Medicine Clinic in the Netherlands. Another practical application of storing umbilical cord blood after birth is that it can be used for cardiovascular diseases. Everybody, right from the parents to the obstetrician, and the concerning blood bank has to be ready for storage before the baby is born. Why? Because, they say, a public pool to draw on is considerably larger than having a single source of blood. A courier from the stem cell bank will come and retrieve the collection kit and transport for processing and storage. If you can afford to harvest and store your newborns cord blood by all means does so. Although only about 2 cups of cord blood can be collected from the umbilical cord at birth, this small amount is rich in these early (primitive) cells. The closer the blood relation of the cell donor means the more likely that these cells will be helpful. On ...From:luisantafeViews:0 0ratingsTime:01:18More inScience Technology

More:
cord blood bank | Cheapest Cord Blood Banking - Video

cord blood | Cord Blood Cells - Advantages Of Extracting Stem Cells From Umbilical Cord
http://www.cordbloodrecommendation.com The real treatment takes place when the patient is infused with stem cells, which start producing white blood cells in order to make the amount of white blood cells reach the normal number. The nerve cells are known as the ""substantia nigra. Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Juvenile Chronic Myelogenous Leukemia Hunter #39;s Syndrome Tay-Sachs Disease Wolman Disease Lesch-Nyhan Syndrome Osteoporosis Beta Thalassemia Major Samples of twin pregnancies were generally rejected due the low availability of cells. The banking facility helps in making blood donation readily available for transplantation #39;s. Flex blood caching can be lifesavers for your family too. She sought umbilical cord blood stem cell therapy from the private Preventative Medicine Clinic in the Netherlands. Stromal cells are a kind of cells that form bone, cartilage, fat, and fibrous connective tissue. Twenty-five children diagnosed with Krabbe #39;s disease were followed and studied regarding their treatments. The National Cord Blood Program staff at the New York Blood Center performs cord blood collection from the expelled placenta. Red blood cells, white blood cells and platelets develop from these cells. The phenomenon is growing fast and the situation is unclear. The blood needs to be collected within 10 to fifteen minutes of birth which is why arrangements must be made ahead of time. If they are able to grow sufficiently, the new cell will make new blood ...From:loshoteles enmedellinViews:0 0ratingsTime:01:18More inScience Technology

See original here:
cord blood | Cord Blood Cells - Advantages Of Extracting Stem Cells From Umbilical Cord - Video

Stem Cells, FDA, Legal and Regulated elsewhere.mov
Rejuvenare on stem cell therapy, not approved by the FDA in the United States but legal and regulated in other countries.From:rejuvenareViews:0 0ratingsTime:00:23More inEducation

Read more:
Stem Cells, FDA, Legal and Regulated elsewhere.mov - Video

stem cell therapy @ kapuso jessica soho
LAMININE It #39;s not often that the perfect super-supplement with the perfect story comes around, but the story of Laminine is far from a mythical tale. As far back as 1929, a Medical Doctor in Canada discovered a way to extract the #39;life-essence #39; of a nine day old fertilized avian egg. Through research, it was found that on exactly the ninth day, all the ingredients necessary to create life are at its #39; highest level. In fact, the life-giving proteins are so potent at this stage that a live chick is hatched a mere two weeks thereafter. This method of extraction and freeze-drying processes proved to be a historical monumental success for this Medical Doctor #39;s patients. 09333737867 for infoFrom:xpalfredViews:1 1ratingsTime:12:00More inHowto Style

Read more:
stem cell therapy @ kapuso jessica soho - Video

blood banks | Facts You May Not Know About Storing Cord Blood
http://www.cordbloodrecommendation.com These findings bring new hope to those who suffer from acute kidney failure, a life threatening condition. One of the studies was carried out by the Wake Forest University which is located in Winston-Salem, N. Lastly, what is their pricing structure like? Trust me, I know that this isn #39;t the time to go bargain hunting, but neither is it the time to be the victim of price-gouging. These trained and knowledgeable individuals will be able to answer any and all questions regarding cord blood storage and the fees and tasks associated with the storage. There is much controversy regarding the use of stem cell research as it pertains to the use of embryos. Extracting bone marrow is a very painful and difficult procedure, and if you have your own blood, then you do not need to make your family members go through the bone marrow transplant procedure. In order to keep it sterilized, it is then cryogenically stored either in a public or private bank until it is needed for transplant. Preserved stem cells are used when the body is in a weakened state from disease or treatments such as chemotherapy. Cord blood stem cell therapy has regenerative characteristics. Stem cell transplants can save lives of people with serious diseases, such as leukemia (cancer of the white blood cells) and other cancers, or those with serious blood disorders (aplastic anemia). There are currently studies which are researching the possibility of using stem cells to treat ...From:loshoteles enmedellinViews:0 0ratingsTime:01:18More inScience Technology

See the original post here:
blood banks | Facts You May Not Know About Storing Cord Blood - Video

The Rejuvenare Experience .mov
Patient Jerry and his wife discuss their Rejuvenare experience in Jerry receiving stem cell therapy for Parkinson #39;s disease. They are very impressed with how fantastic the experience has been and wonders how Rejuvenare can offer such excellent services to its patient clients.From:rejuvenareViews:0 0ratingsTime:01:11More inEducation

View post:
The Rejuvenare Experience .mov - Video

Rejuvenare stem cell treatment for stroke.mov
Rejuvenare CEO Carlo Velarde relates how his mother, completely incapacitated by a crippling stroke, has regained her quality of life, her mobility, her thought process after undergoing stem cell therapy for stroke.From:rejuvenareViews:0 0ratingsTime:00:47More inEducation

Excerpt from:
Rejuvenare stem cell treatment for stroke.mov - Video

Rejuvenare - I don #39;t have time to wait for approval in the US
Patient Jerry relates why he chose Rejuvenare stem cell therapy to treat Parkinson #39;s outside the US. Although he #39;d earlier been successful keeping the disease #39;s progression slowed, they were no longer effective for him and he was told it would be about 10 years before this procedure was approved in the USFrom:rejuvenareViews:0 0ratingsTime:01:24More inEducation

View post:
Rejuvenare - I don't have time to wait for approval in the US - Video

VCARE STEM CELL THERAPY
Vcare has launched two treatments options based on stem cell products, one for diffused alopecia, the reversible form of hair loss and one for Androgenetic alopecia, commonly called as "Baldness".From:VCare TrichologyViews:1 0ratingsTime:04:36More inHowto Style

Read more here:
VCARE STEM CELL THERAPY - Video